 UBS Group AG trimmed its holdings in Deciphera Pharmaceuticals Inc NASDAQ:DCPH by 70.7 in the 1st quarter, HoldingsChannel.com reports. The fund owned 2,945 shares of the companys stock after selling 7,109 shares during the quarter. UBS Group AGs holdings in Deciphera Pharmaceuticals were worth 121,000 as of its most recent SEC filing. Other hedge funds ... 